NCT05222594 Computational Neuroscience of Language Processing in the Human Brain
| NCT ID | NCT05222594 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Massachusetts General Hospital |
| Condition | Language |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2021-04-02 |
| Primary Completion | 2027-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2021-04-02 with a primary completion date of 2027-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Language is a signature human cognitive skill, but the precise computations that support language understanding remain unknown. This study aims to combine high-quality human neural data obtained through intracranial recordings with advances in computational modeling of human cognition to shed light on the construction and understanding of speech.
Eligibility Criteria
Inclusion Criteria: * clinical indications to proceed with intracranial monitoring involving the left cerebral hemisphere, as determined by a multidisciplinary epilepsy surgery team * the ability to comply with test directions and provide informed consent * between ages 18 - 85 Exclusion Criteria: * inability to understand or perform the task outlined in the protocol, or who are unwilling or unable to participate
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05222594 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Language. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05222594 currently recruiting?
Yes, NCT05222594 is actively recruiting participants. Contact the research team at evelina9@mit.edu for enrollment information.
Where is the NCT05222594 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT05222594 clinical trial?
NCT05222594 is sponsored by Massachusetts General Hospital. The trial plans to enroll 40 participants.